查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2104550

下肢植入市場：依類型、生物材料、最終用戶、國家及地區分類－全球產業分析、市場規模、市場佔有率及2026年至2033年預測

Lower Extremity Implants Market, By Type, By Biomaterial, By End User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2026-2033
出版日期: | 出版商: AnalystView Market Insights | 英文 358 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2025年下肢植入市場價值為141.94億美元，預計從2026年到2033年將以3.8%的複合年成長率成長。

下肢植入是客製化的整形外科醫療設備，用於替換由退化性疾病、骨折和運動傷害引起的關節不穩定、骨骼移位和結構畸形。它們在髖關節、膝關節、足部和踝植入中發揮著重作用。這些植入物採用生物醫療設備和先進的鎖定機制，有助於提高患者的活動能力，並延長其在醫院、門診手術中心和整形外科診所的使用壽命。

諸如患者客製化植入和多孔結構等創新技術，以及機器人輔助手術的快速普及，正在提高手術精確度。經合組織的報告顯示，到2025年，髖關節和膝關節關節重建仍將是成員國最常見的擇期整形外科手術之一，這反映出持續的手術需求。隨著預期壽命的延長和老齡化社會的日益活躍，人們對耐磨性、解剖學設計和微創植入的需求也日益成長。

下肢植入市場—市場動態

退化性關節疾病和整形外科手術負擔加重

隨著骨關節炎、老齡化相關疾病和肌肉骨骼問題的發病率不斷上升，人們對能夠提供最佳活動能力並減輕長期功能障礙的可靠下肢重組植入技術的需求日益成長。術後植入性能的提高和重新置換手術的減少，促使臨床醫生越來越傾向於採用新型材料、先進的承載面、強化固定塗層和導向式膝關節植入植入等技術的膝關節和髖關節植入物。受年齡、運動傷害和肥胖等因素的影響，患者數量正在增加。此外，世界衛生組織（WHO）預測，到2025年，肌肉骨骼疾病將成為導致殘疾的主要原因，影響全球約17.1億人。這一事實進一步凸顯了最佳化整形外科植入的必要性。巨大的全球疾病負擔正在推動植入材料和手術規劃系統的快速技術進步，以及機器人輔助整形外科手術的日益普及。

下肢植入市場－市場區隔分析：

全球下肢植入市場按類型、生物材料、最終用戶和地區進行細分。

髖植入市場是最大的細分市場，髖關節置換術仍然是治療進行進行性髖關節骨性關節炎、股骨頸骨折和股骨頭缺血性的最佳選擇。針對這些適應症，髖植入製造商正致力於透過創新現有的髀臼組件、股骨柄、雙動式植入和無骨水泥固定方法，來提高這些解決方案的耐用性並降低植入失效率。雖然由於骨關節炎盛行率的上升，膝關節移植手術仍然居高不下，但人們對足踝植入物的認知不斷提高，整形外科重組手術的增加，以及對需要解剖學精準匹配的運動應用日益成長的興趣，正在推動足踝植入市場的快速成長。到2025年，美國關節關節重建註冊中心收集的數據將繼續建構和完善一個全國性的髖關節和膝關節關節重建資料庫，從而支持對各種植入技術進行客觀、數據驅動的比較評估。

金屬生物材料是植入生物材料中的絕大多數。這是因為它們具有優異的強度、斷裂韌性、疲勞壽命、耐腐蝕性和耐磨性，這些都是承重整形外科植入必不可少的機械性能。近年來，利用特定表面紋理和先進多孔金屬結構的創新技術最佳化了植入與生物骨之間的骨整合，實現了無骨水泥固定。陶瓷生物材料因其優異的承載表面性能而常被使用，這些性能可最大限度地減少磨損；而高交聯聚乙烯等聚合物生物材料有時因其能顯著降低摩擦而被用於關節部位。目前，美國食品藥物管理局（FDA）正在批准各種創新整形外科生物材料及相關技術，這促進了低孔隙率、高強度和高耐久性人工髖關節置換材料的多樣化發展。

下肢植入市場—區域分析

北美擁有成熟的整形外科醫療生態系統，包括專業的關節重建中心、優惠的保險報銷機制以及機器人輔助手術的廣泛應用，因此在下肢植入應用方面處於領先地位。美國憑藉其完善的醫療基礎設施和眾多使用各種數位化手術規劃系統的骨科醫生，佔據了市場的大部分佔有率。而在鄰國加拿大，人口老化推動了擇期整形外科計畫的擴展，從而刺激了需求的成長。隨著美國整形外科學會（AAOS）於2025年發布的報告繼續鼓勵制定基於實證醫學的髖關節和膝關節關節重建臨床實踐指南，北美人工關節市場正經歷著快速成長和產品創新。

由於醫療產業的現代化、整形外科專科診所的增加以及先進手術的普及，亞太地區對下肢植入的需求正經歷著急劇成長。透過增加對外科培訓和本土植入生產的投入，整形外科技術水準顯著提高，使得微創關節關節重建手術在包括印度、中國和日本在內的多個國家得到廣泛應用。人口老化以及老年人追求積極生活方式的願望進一步推動了這一成長，導致接受此類重組手術的人數不斷增加。過去十年，到2025年，日本厚生勞動省宣布老年人口（65歲及以上）將佔總人口的約30%，這將進一步增加對這類專業整形外科手術的整體需求。

目錄

第1章：下肢植入市場概述

  • 分析範圍
  • 市場估算期

第2章執行摘要

  • 市場區隔
  • 競爭考察

第3章：下肢植入的主要市場趨勢

  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 未來市場趨勢

第4章：下肢植入產業分析

  • PEST分析
  • 波特五力分析
  • 市場成長前景展望圖
  • 管理體制分析

第5章 下肢植入市場：地緣政治緊張局勢加劇的影響

  • 新冠疫情的影響
  • 俄烏戰爭的影響
  • 中東衝突的影響

第6章：植入市場趨勢

  • 下肢植入市佔率分析，2025 年
  • 主要製造商的細分數據
    • 對現有公司的分析
    • 新興企業分析

第7章 下肢植入市場：依類型分類

  • 概述
    • 基於細分市場的市場佔有率分析：按類型
    • 髖關節
    • 膝蓋
    • 腳和腳踝

第8章 下肢植入市場：依生物材料分類

  • 概述
    • 細分市場佔有率分析：依生物材料分類
    • 陶瓷生物材料
    • 金屬生物材料
    • 以聚合物為基礎的生物材料
    • 天然生物材料

第9章 下肢植入市場：依最終用戶分類

  • 概述
    • 基於細分市場的市場佔有率分析：按最終用戶分類
    • 門診手術中心
    • 醫院
    • 診所
    • 其他

第10章 下肢植入市場：依地區分類

  • 介紹
  • 北美洲
    • 概述
    • 主要製造商：北美
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 主要製造商：歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 瑞典
    • 俄羅斯
    • 波蘭
    • 丹麥
    • 其他歐洲國家
  • 亞太地區
    • 概述
    • 主要製造商：亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 菲律賓
    • 台灣
    • 越南
    • 其他亞太國家
  • 拉丁美洲
    • 概述
    • 主要製造商：拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 其他拉丁美洲國家
  • 中東和非洲
    • 概述
    • 主要生產商：中東和非洲
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • 伊朗
    • 卡達
    • 其他中東和非洲國家

第11章：主要供應商分析：下肢植入產業

  • 競爭基準
    • 競爭對手儀錶板
    • 競爭定位
  • 公司簡介
    • DePuy Synthes（Johnson & Johnson）
    • Stryker Corporation
    • Zimmer Biomet Holdings, Inc.
    • Smith+Nephew plc
    • Arthrex, Inc.
    • CONMED Corporation
    • Enovis Corporation（formerly DJO Global）
    • Orthofix Medical Inc.
    • Paragon 28, Inc.
    • Acumed LLC
    • Integra LifeSciences Holdings Corporation
    • Exactech, Inc.
    • Ossur hf
    • OsteoMed
    • Others

第12章：AnalystView 的全景視圖

簡介目錄
Product Code: ANV7151

Lower Extremity Implants Market size was valued at US$ 14,109.4 Million in 2025, expanding at a CAGR of 3.8% from 2026 to 2033.

Lower extremity implants are custom-made orthopedic devices that replace destabilized joints, misplaced bones, and deformed structures caused by degenerative diseases, fractures, and sports injuries for load-bearing purposes in hip, knee, foot, and ankle implants. Implanting medical device biomaterials and modern locking methods, the devices contribute to improved mobility with longer operating lives in hospitals, ASCs, and orthopedic surgical practices.

Innovation through patient-specific and porous nature of implants, alongside the use of robotic-based procedures, has surged, improving the level of accuracy in surgery. In 2025, the OECD reported that hip and knee replacement procedures continue to rank among the most frequently performed elective orthopedic surgeries across member nations, reflecting sustained procedural demand. With increased life expectancies and an active aging population driving the need for enhanced wear properties, anatomical designs, and minimally invasive implantation procedures.

Lower Extremity Implants Market- Market Dynamics

Rising Burden of Degenerative Joint Disorders and Orthopedic Procedures

The growing incidence of osteoarthritis and age-related diseases, along with musculoskeletal problems, has accelerated the requirements for robust lower extremity reconstructed implant technologies designed to offer the best mobility and reduce long-term disability. With improving postoperative implant performance and lower revision implant surgery procedures, there has been a rising preference among clinicians for knee and hip implants loaded with new materials, advanced bearing surfaces, enhanced fixation coatings, and guided knee implants. Besides age-specific patients, other factors such as sports injuries and obesity are increasing the patient population. Moreover, in the year 2025, the World Health Organization stated that musculoskeletal conditions are a chief factor for disability, influencing nearly 1.71 billion people around the world- a fact reinforcing the need for optimized orthopedic implants. A huge global burden of disease drives rapid technological advancements in implant materials, planning surgical systems, and the growth of robotically-assisted orthopedic surgery.

Lower Extremity Implants Market- Segmentation Analysis:

The Global Lower Extremity Implants Market is segmented on the basis of Type, Biomaterial, End User, and Region.

The hip implant market largest segment where hip arthroplasty continues to be the best treatment alternative for treating the deteriorating effects of advanced osteoarthritis of the hip, the hip's femoral neck fractures, and hip's avascular necrosis. For these applications, hip implant manufacturers are innovating current acetabular components, femoral stems, dual-mobility implants, and cementless fixation so that these solutions become increasingly resilient and result in reduced rates of implant failure. Even though knee implants continue to experience large procedural volumes in response to the increasing incidence of osteoarthritis, increased awareness, reconstructive orthopedic procedures, and a greater interest in sports applications requiring anatomically precise fit have fueled rapid market growth in the foot and ankle implants market. In 2025, data collected by the American Joint Replacement Registry continued to inform and develop its nationwide database of hip and knee arthroplasty procedures, supporting objective, data-driven comparative evaluations of different implant technologies.

Metallic biomaterials account for the overwhelming majority of implant biomaterials because they offer excellent strength, fracture toughness, fatigue life, corrosion resistance, and wear properties-crucial mechanical characteristics for load-bearing orthopedic implants. Through recent innovations that leverage specific surface texturing and sophisticated porous metallic geometries, osseointegration between the implant and native bone has been optimized, allowing for non-cemented implant fixation. Ceramic-based biomaterials are frequently employed for their superior bearing surface properties, which minimize wear, while polymer biomaterials like highly cross-linked polyethylene may be preferred in articulation to significantly decrease friction. Various U.S. Food and Drug Administration (FDA) approvals are now provided for a range of innovative orthopedic biomaterials and related technologies, supporting an increased variety of less porous, stronger, and more durable hip replacements.

Lower Extremity Implants Market- Geographical Insights

A mature orthopedic care ecosystem supported by specialized joint replacement centers, favorable reimbursement structures, and widespread adoption of robotic-assisted surgery positions North America at the forefront of lower extremity implant utilization. While the United States contributes most of the volume through well-established medical facility infrastructures and an abundant number of orthopedic surgeons practicing through various digital surgical planning systems, the neighboring country Canada contributes to growing demands driven by the expanding elective orthopedic program as the aging demographic grows. According to a report published by the American Academy of Orthopaedic Surgeons (AAOS) in 2025, continuing to encourage the development of evidence-based clinical practice guidelines for hip and knee arthroplasty, the North American market for implants has witnessed rapid growth and product innovation.

The demand for lower extremity implant products in the Asia-Pacific region has experienced a dramatic surge due to modernization of the healthcare industry, growth in specialty orthopedic clinics, and increased health access for sophisticated surgeries. With significant growth in orthopedic expertise through investments in surgeon training and domestic manufacturing of implants, several countries such as India, China, and Japan have extensively started adopting minimally invasive joint replacement surgical procedures. This growth is further supported by an increasing aging demographic and their desire for active lifestyles, leading them to undergo such reconstructive surgeries. In the last decade of 2025, the Japanese Ministry of Health, Labour and Welfare announced that their country's elderly population has occupied about 30% of the entire population (aged 65+), thus raising overall demand in this specialty orthopedic surgery.

Lower Extremity Implants Market- Competitive Landscape:

Competitive positioning is based more on factors such as the lifetime of implants, integration with digitized surgery, robotic capabilities, biomaterial technology, and process optimization, rather than just a broad product range. Companies develop patient-specific implants, 3D printing, intelligent instruments, and artificial intelligence technologies, which help align implants and enhance results. The vertical integration of processes from manufacturing implants to surgical services and navigation software is one of the key competitive advantages of multinational manufacturers. In 2025, Zimmer Biomet extended the ROSA(R) robotic surgery solutions line along with their orthopedic implants due to continuous implementation programs, strengthening procedural efficiency and reinforcing technology-driven differentiation within the lower extremity implant industry.

Recent Developments:

In February 2025, Stryker launched the robotic-assisted surgical technology - expanded use of its Mako SmartRobotics applications for implant surgeries such as the hip and knee that improve surgical workflow and increase robotic accuracy.

In April 2025, Zimmer Biomet released new features on their ROSA Knee System via official product releases that enhance planning, robotic positioning, and interconnectedness between the two fields of digital imaging in an operating room.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL LOWER EXTREMITY IMPLANTS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • DePuy Synthes (Johnson & Johnson)
  • Stryker Corporation
  • Zimmer Biomet Holdings, Inc.
  • Smith+Nephew plc
  • Arthrex, Inc.
  • CONMED Corporation
  • Enovis Corporation (formerly DJO Global)
  • Orthofix Medical Inc.
  • Paragon 28, Inc.
  • Acumed LLC
  • Integra LifeSciences Holdings Corporation
  • Exactech, Inc.
  • Ossur hf
  • OsteoMed
  • Others

GLOBAL LOWER EXTREMITY IMPLANTS MARKET, BY TYPE- MARKET ANALYSIS, 2020 - 2033

  • Hip
  • Knee
  • Foot & Ankle

GLOBAL LOWER EXTREMITY IMPLANTS MARKET, BY BIOMATERIAL- MARKET ANALYSIS, 2020 - 2033

  • Ceramic Biomaterials
  • Metallic Biomaterials
  • Polymeric Biomaterials
  • Natural Biomaterials

GLOBAL LOWER EXTREMITY IMPLANTS MARKET, BY END USER- MARKET ANALYSIS, 2020 - 2033

  • Ambulatory Surgery Centers
  • Hospitals
  • Clinics
  • Others

GLOBAL LOWER EXTREMITY IMPLANTS MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Denmark
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Taiwan
  • Vietnam
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Iran
  • Qatar
  • Rest of MEA

Table of Contents

1. Lower Extremity Implants Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Lower Extremity Implants Market Snippet by Type
    • 2.1.2. Lower Extremity Implants Market Snippet by Biomaterial
    • 2.1.3. Lower Extremity Implants Market Snippet by End User
    • 2.1.4. Lower Extremity Implants Market Snippet by Country
    • 2.1.5. Lower Extremity Implants Market Snippet by Region
  • 2.2. Competitive Insights

3. Lower Extremity Implants Key Market Trends

  • 3.1. Lower Extremity Implants Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Lower Extremity Implants Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Lower Extremity Implants Market Opportunities
  • 3.4. Lower Extremity Implants Market Future Trends

4. Lower Extremity Implants Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Lower Extremity Implants Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Lower Extremity Implants Market Landscape

  • 6.1. Lower Extremity Implants Market Share Analysis, 2025
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Lower Extremity Implants Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2025 & 2033 (%)
    • 7.1.2. Hip
    • 7.1.3. Knee
    • 7.1.4. Foot & Ankle

8. Lower Extremity Implants Market - By Biomaterial

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Biomaterial, 2025 & 2033 (%)
    • 8.1.2. Ceramic Biomaterials
    • 8.1.3. Metallic Biomaterials
    • 8.1.4. Polymeric Biomaterials
    • 8.1.5. Natural Biomaterials

9. Lower Extremity Implants Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2025 & 2033 (%)
    • 9.1.2. Ambulatory Surgery Centers
    • 9.1.3. Hospitals
    • 9.1.4. Clinics
    • 9.1.5. Others

10. Lower Extremity Implants Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Lower Extremity Implants Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Biomaterial, 2020 - 2033 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Biomaterial, 2020 - 2033 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Biomaterial, 2020 - 2033 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Lower Extremity Implants Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Biomaterial, 2020 - 2033 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Biomaterial, 2020 - 2033 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.3.8. UK
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.8.3. UK Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.3.8.4. UK Market Size and Forecast, By Biomaterial, 2020 - 2033 (US$ Million)
      • 10.3.8.5. UK Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.3.9. France
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.9.3. France Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.3.9.4. France Market Size and Forecast, By Biomaterial, 2020 - 2033 (US$ Million)
      • 10.3.9.5. France Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.3.10. Italy
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.10.3. Italy Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.3.10.4. Italy Market Size and Forecast, By Biomaterial, 2020 - 2033 (US$ Million)
      • 10.3.10.5. Italy Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.3.11. Spain
      • 10.3.11.1. Overview
      • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.11.3. Spain Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.3.11.4. Spain Market Size and Forecast, By Biomaterial, 2020 - 2033 (US$ Million)
      • 10.3.11.5. Spain Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.3.12. The Netherlands
      • 10.3.12.1. Overview
      • 10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.12.3. The Netherlands Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.3.12.4. The Netherlands Market Size and Forecast, By Biomaterial, 2020 - 2033 (US$ Million)
      • 10.3.12.5. The Netherlands Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Overview
      • 10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Biomaterial, 2020 - 2033 (US$ Million)
      • 10.3.13.5. Sweden Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.3.14. Russia
      • 10.3.14.1. Overview
      • 10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.14.3. Russia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.3.14.4. Russia Market Size and Forecast, By Biomaterial, 2020 - 2033 (US$ Million)
      • 10.3.14.5. Russia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.3.15. Poland
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.15.3. Poland Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.3.15.4. Poland Market Size and Forecast, By Biomaterial, 2020 - 2033 (US$ Million)
      • 10.3.15.5. Poland Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.3.16. Denmark
      • 10.3.16.1. Overview
      • 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.16.3. Denmark Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.3.16.4. Denmark Market Size and Forecast, By Biomaterial, 2020 - 2033 (US$ Million)
      • 10.3.16.5. Denmark Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.3.17. Rest of Europe
      • 10.3.17.1. Overview
      • 10.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.17.3. Rest of the Europe Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.3.17.4. Rest of the Europe Market Size and Forecast, By Biomaterial, 2020 - 2033 (US$ Million)
      • 10.3.17.5. Rest of the Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Lower Extremity Implants Key Manufacturers in Asia Pacific
    • 10.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 10.4.4. APAC Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
    • 10.4.5. APAC Market Size and Forecast, By Biomaterial, 2020 - 2033 (US$ Million)
    • 10.4.6. APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.4.7. China
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.7.3. China Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.4.7.4. China Market Size and Forecast, By Biomaterial, 2020 - 2033 (US$ Million)
      • 10.4.7.5. China Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.4.8. India
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.8.3. India Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.4.8.4. India Market Size and Forecast, By Biomaterial, 2020 - 2033 (US$ Million)
      • 10.4.8.5. India Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Biomaterial, 2020 - 2033 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Biomaterial, 2020 - 2033 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Biomaterial, 2020 - 2033 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.4.12. Indonesia
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.12.3. Indonesia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.4.12.4. Indonesia Market Size and Forecast, By Biomaterial, 2020 - 2033 (US$ Million)
      • 10.4.12.5. Indonesia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.4.13. Thailand
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.13.3. Thailand Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.4.13.4. Thailand Market Size and Forecast, By Biomaterial, 2020 - 2033 (US$ Million)
      • 10.4.13.5. Thailand Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Biomaterial, 2020 - 2033 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.4.15. Taiwan
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.15.3. Taiwan Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.4.15.4. Taiwan Market Size and Forecast, By Biomaterial, 2020 - 2033 (US$ Million)
      • 10.4.15.5. Taiwan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.4.16. Vietnam
      • 10.4.16.1. Overview
      • 10.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.16.3. Vietnam Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.4.16.4. Vietnam Market Size and Forecast, By Biomaterial, 2020 - 2033 (US$ Million)
      • 10.4.16.5. Vietnam Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.4.17. Rest of APAC
      • 10.4.17.1. Overview
      • 10.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.17.3. Rest of APAC Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.4.17.4. Rest of APAC Market Size and Forecast, By Biomaterial, 2020 - 2033 (US$ Million)
      • 10.4.17.5. Rest of APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 10.5. Latin America (LATAM)
    • 10.5.1. Overview
    • 10.5.2. Lower Extremity Implants Key Manufacturers in Latin America
    • 10.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 10.5.4. LATAM Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
    • 10.5.5. LATAM Market Size and Forecast, By Biomaterial, 2020 - 2033 (US$ Million)
    • 10.5.6. LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Biomaterial, 2020 - 2033 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Biomaterial, 2020 - 2033 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Biomaterial, 2020 - 2033 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Biomaterial, 2020 - 2033 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Biomaterial, 2020 - 2033 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 10.6. Middle East and Africa (MEA)
    • 10.6.1. Overview
    • 10.6.2. Lower Extremity Implants Key Manufacturers in Middle East and Africa
    • 10.6.3. MEA Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 10.6.4. MEA Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
    • 10.6.5. MEA Market Size and Forecast, By Biomaterial, 2020 - 2033 (US$ Million)
    • 10.6.6. MEA Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Biomaterial, 2020 - 2033 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.6.8. UAE
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.8.3. UAE Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.6.8.4. UAE Market Size and Forecast, By Biomaterial, 2020 - 2033 (US$ Million)
      • 10.6.8.5. UAE Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Biomaterial, 2020 - 2033 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Biomaterial, 2020 - 2033 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Biomaterial, 2020 - 2033 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Biomaterial, 2020 - 2033 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.6.13. Iran
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.13.3. Iran Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.6.13.4. Iran Market Size and Forecast, By Biomaterial, 2020 - 2033 (US$ Million)
      • 10.6.13.5. Iran Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.6.14. Qatar
      • 10.6.14.1. Overview
      • 10.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.14.3. Qatar Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.6.14.4. Qatar Market Size and Forecast, By Biomaterial, 2020 - 2033 (US$ Million)
      • 10.6.14.5. Qatar Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 10.6.15. Rest of MEA
      • 10.6.15.1. Overview
      • 10.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.15.3. Rest of MEA Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 10.6.15.4. Rest of MEA Market Size and Forecast, By Biomaterial, 2020 - 2033 (US$ Million)
      • 10.6.15.5. Rest of MEA Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)

11. Key Vendor Analysis- Lower Extremity Implants Industry

  • 11.1. Competitive Benchmarking
    • 11.1.1. Competitive Dashboard
    • 11.1.2. Competitive Positioning
  • 11.2. Company Profiles
    • 11.2.1. DePuy Synthes (Johnson & Johnson)
    • 11.2.2. Stryker Corporation
    • 11.2.3. Zimmer Biomet Holdings, Inc.
    • 11.2.4. Smith+Nephew plc
    • 11.2.5. Arthrex, Inc.
    • 11.2.6. CONMED Corporation
    • 11.2.7. Enovis Corporation (formerly DJO Global)
    • 11.2.8. Orthofix Medical Inc.
    • 11.2.9. Paragon 28, Inc.
    • 11.2.10. Acumed LLC
    • 11.2.11. Integra LifeSciences Holdings Corporation
    • 11.2.12. Exactech, Inc.
    • 11.2.13. Ossur hf
    • 11.2.14. OsteoMed
    • 11.2.15. Others

12. 360 Degree AnalystView

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us